查詢結果分析
相關文獻
- Quercetin Enhances Tamoxifen-induced Antitumor Activity through Down-regulation of Cyclin E2 Expression in Drug-resistant Human Breast Cancer Cells
- 源自飲食的Biochanin A對人類乳癌細胞生長影響的分析
- 游離放射線對乳癌細胞細胞週期及移動機轉之影響
- 傳統中藥方劑對人類乳癌細胞增生抑制作用和細胞程式死亡機制之探討
- Analysis of Spatial Transcriptomics of MARCH5 and Its Potential Role in Cell Proliferation in Breast Cancers
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Cystic Hypersecretory Intraductal Carcinoma of the Breast--Case Report
- Timing of Shoulder Exercise after Modified Radical Mastectomy: A Prospective Study
- 前哨淋巴掃描診斷乳癌早期轉移
頁籤選單縮合
題名 | Quercetin Enhances Tamoxifen-induced Antitumor Activity through Down-regulation of Cyclin E2 Expression in Drug-resistant Human Breast Cancer Cells=槲黃素透過細胞週期蛋白Cyclin E2的抑制作用增強對Tamoxifen抗藥性乳癌細胞之抗癌作用 |
---|---|
作者 | 杜世興; 楊國卿; 何其儻; 黃清水; 陳清祥; 張慧文; 張鑑熹; 吳志雄; 何元順; Tu, Shih-hsin; Yang, Kuo-ching; Ho, Chi-tang; Huang, Ching-shui; Chen, Ching-shyang; Chang, Hui-wen; Chang, Chien-hsi; Wu, Chih-hsiung; Ho, Yuan-soon; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20131200 |
卷期 | 29:4 2013.12[民102.12] |
頁次 | 頁167-181 |
分類號 | 418.31 |
語文 | eng |
關鍵詞 | 槲黃素; 細胞週期蛋白cyclin E2; 乳癌; 諾瓦得士錠; 細胞週期; Quercetin; CCNE2; Breast cancer; Tamoxifen; Cell cycle; |
中文摘要 | 目的:槲黃素(quercetin)可以在許多植物組織中發現,是一種類黃酮成分。槲黃素的抗乳 癌作用主要是化學預防與作為化學治療藥物的增強作用。至於它在乳癌細胞內真正作用 於何種致癌蛋白並未有任何報導。 材料方法:本實驗利用即時反轉錄酶鏈鎖反應(real-time reverse-transcriptase polymerase chain reaction)分析細胞週期蛋白 cyclin E2 (CCNE2) mRNA 在 213 位乳癌病人身上的表現 情況,並利用 MCF7 乳癌細胞株作為研究模式,探討槲黃素之抑制 CCNE2 的作用機制。 結果:證實 CCNE2 mRNA 在癌組織中的表現明顯高於正常組織約 3.55 倍 (*P = 0.005)。 證實 CCNE2 蛋白在 Tamoxifen 抗藥性 MCF-7 細胞株(TAM-R)中,CCNE2 高表現。此種 TAM-R 細胞株 CCNE2 高表現可以被槲黃素(5 μM)所抑制。合併處理槲黃素與 Tamoxifen 可以使抗藥性 MCF-7 細胞株對藥物的敏感度增加。 結論:槲黃素有潛力與 Tamoxifen 作為合併使用,可以使抗藥性 MCF-7 細胞株對藥物的 敏感度增加,並增加化療效果解決乳癌病人抗藥性的問題。 |
英文摘要 | Quercetin is found in plant tissues known as flavonoids, and contains properties that act as a chemopreventive or chemosensitizer agent against human breast cancer. However, the oncogenic molecule inhibited by quercetin treatment has still not been identified in human breast cancer cells. The cyclin E2 (CCNE2) mRNA levels were demonstrated to be higher in tumor cells (3.55-fold, *P = 0.005) than in normal paired tissue samples, using real-time reversetranscriptase polymerase chain reaction (RT-PCR) analysis (n = 213). We further demonstrated that relatively higher levels of CCNE2 protein expression were detected in the tamoxifenresistant (TAM-R) MCF-7 cells. The results showed that CCNE2 protein expression levels were specifically inhibited in quercetin-treated (5 μM) TAM-R cells, either in the presence or absence of 4-OH-TAM (100 nM). Additionally, it was noted that combination treatment with 4-OH-TAM and quercetin significantly sensitized TAM-R cells to 4-OH-TAM. This study suggests that quercetin can be used as a chemosensitizer by targeting CCNE2 expression levels, which may be a novel strategy to overcome TAM resistance in breast cancer patients. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。